30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective

Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.

Automated summary

Emerging evidence from clinical trials suggests that optimizing CIK cell therapy in combination with other contemporary cancer therapies may be key in combating cancer.